188 related articles for article (PubMed ID: 9823867)
1. Tumors of the pancreas with osteoclast-like and pleomorphic giant cells: an immunohistochemical and ploidy study.
Deckard-Janatpour K; Kragel S; Teplitz RL; Min BH; Gumerlock PH; Frey CF; Ruebner BH
Arch Pathol Lab Med; 1998 Mar; 122(3):266-72. PubMed ID: 9823867
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
Hoorens A; Prenzel K; Lemoine NR; Klöppel G
J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
[TBL] [Abstract][Full Text] [Related]
3. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region.
Molberg KH; Heffess C; Delgado R; Albores-Saavedra J
Cancer; 1998 Apr; 82(7):1279-87. PubMed ID: 9529019
[TBL] [Abstract][Full Text] [Related]
4. K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium.
Westra WH; Sturm P; Drillenburg P; Choti MA; Klimstra DS; Albores-Saavedra J; Montag A; Offerhaus GJ; Hruban RH
Am J Surg Pathol; 1998 Oct; 22(10):1247-54. PubMed ID: 9777987
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells.
Nojima T; Nakamura F; Ishikura M; Inoue K; Nagashima K; Kato H
Int J Pancreatol; 1993 Dec; 14(3):275-81. PubMed ID: 8113629
[TBL] [Abstract][Full Text] [Related]
6. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
7. Osteoclast-like giant cell tumor of the pancreas with metastases to gallbladder and lymph nodes. A case report.
Sun AP; Ohtsuki Y; Liang SB; Sonobe H; Iwata J; Furihata M; Takeuchi T; Qiu Y; Chen BK; Watanabe R; Ohmori K
Pathol Res Pract; 1998; 194(8):587-94; discussion 595. PubMed ID: 9779494
[TBL] [Abstract][Full Text] [Related]
8. Gastric carcinoma with osteoclast-like giant cells.
Baschinsky DY; Frankel WL; Niemann TH
Am J Gastroenterol; 1999 Jun; 94(6):1678-81. PubMed ID: 10364044
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma.
Mentzel T; Calonje E; Fletcher CD
Am J Surg Pathol; 1994 Mar; 18(3):258-65. PubMed ID: 8116793
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and molecular analysis of giant cell carcinoma of the pancreas: a report of three cases.
Imai Y; Morishita S; Ikeda Y; Toyoda M; Ashizawa T; Yamamoto K; Inoue T; Ishikawa T
Pancreas; 1999 Apr; 18(3):308-15. PubMed ID: 10206490
[TBL] [Abstract][Full Text] [Related]
11. Mixed pleomorphic-osteoclast-like tumor of the pancreas. Light microscopical, immunohistochemical, and molecular biological studies.
Gatteschi B; Saccomanno S; Bartoli FG; Salvi S; Liu G; Pugliese V
Int J Pancreatol; 1995 Oct; 18(2):169-75. PubMed ID: 8530833
[TBL] [Abstract][Full Text] [Related]
12. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.
Hoorens A; Lemoine NR; McLellan E; Morohoshi T; Kamisawa T; Heitz PU; Stamm B; Rüschoff J; Wiedenmann B; Klöppel G
Am J Pathol; 1993 Sep; 143(3):685-98. PubMed ID: 8362971
[TBL] [Abstract][Full Text] [Related]
14. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
15. The osteoclast-type giant cell tumor of the pancreas.
Berendt RC; Shnitka TK; Wiens E; Manickavel V; Jewell LD
Arch Pathol Lab Med; 1987 Jan; 111(1):43-8. PubMed ID: 2432851
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PCNA, p53, K-ras and LOH in endocrine pancreas tumors.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
Hepatogastroenterology; 2000; 47(33):875-9. PubMed ID: 10919051
[TBL] [Abstract][Full Text] [Related]
17. [Gastric stromal tumor with osteoclast-like multinucleated giant cells during Lynch II syndrome].
Joseph-Reinette C; Viguier J; Regimbeau C; De Muret A; De Calan L; Dorval E
Gastroenterol Clin Biol; 2000; 24(6-7):675-8. PubMed ID: 10962393
[TBL] [Abstract][Full Text] [Related]
18. Unusual mesenchymal and mixed tumors of the salivary gland. An immunohistochemical and flow cytometric analysis of three cases.
Bocklage T; Feddersen R
Arch Pathol Lab Med; 1995 Jan; 119(1):69-74. PubMed ID: 7802557
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid carcinoma of the prostate: progression from adenocarcinoma is associated with p53 over-expression.
Delahunt B; Eble JN; Nacey JN; Grebe SK
Anticancer Res; 1999; 19(5B):4279-83. PubMed ID: 10628387
[TBL] [Abstract][Full Text] [Related]
20. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas and periampullary region.
Deckard-Janatpour K; Teplitz RL; Min BH; Ruebner BH; Gumerlock PH
Cancer; 1998 Sep; 83(5):1051-2. PubMed ID: 9731912
[No Abstract] [Full Text] [Related]
[Next] [New Search]
